| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Division of Endocrinology, Department of Medicine, St. Hedwig Hospital, 10115 Berlin, Germany; Humboldt University Berlin, Berlin, Germany; and Faculty of Biology, Aston University (E.A.), B4 7ET Birmingham, United Kingdom
Address all correspondence and requests for reprints to: Dr. Michael Derwahl, St. Hedwig Hospital, Grosse Hamburger Strasse 5-11, 10115 Berlin, Germany. E-mail: m.derwahl{at}alexius.de
Thyroid tumors are about 3 times more frequent in females than in
males. Epidemiological studies suggest that the use of estrogens may
contribute to the pathogenesis of thyroid tumors. In a very recent
study a direct growth stimulatory effect of 17ß-estradiol was
demonstrated in FRTL-5 rat thyroid cells. In this work the presence of
estrogen receptors
and ß in thyroid cells derived from human
goiter nodules and in human thyroid carcinoma cell line HTC-TSHr was
demonstrated. There was no difference between the expression levels of
estrogen receptor
in males and females, but there was a significant
increase in expression levels in response to 17ß-estradiol.
Stimulation of benign and malignant thyroid cells with 17ß-estradiol
resulted in an increased proliferation rate and an enhanced expression
of cyclin D1 protein, which plays a key role in the regulation of
G1/S transition in the cell cycle. In malignant tumor cells
maximal cyclin D1 expression was observed after 3 h, whereas in
benign cells the effect of 17ß-estradiol was delayed. ICI 182780, a
pure estrogen antagonist, prevented the effects of 17ß-estradiol. In
addition, 17ß-estradiol was found to modulate activation of
mitogen-activated protein (MAP) kinase, whose activity is mainly
regulated by growth factors in thyroid carcinoma cells. In response to
17ß-estradiol, both MAP kinase isozymes, extracellular
signal-regulated protein kinases 1 and 2, were strongly phosphorylated
in benign and malignant thyroid cells. Treatment of the cells with
17ß-estradiol and MAP kinase kinase 1 inhibitor, PD 098059, prevented
the accumulation of cyclin D1 and estrogen-mediated mitogenesis. Our
data indicate that 17ß-estradiol is a potent mitogen for benign and
malignant thyroid tumor cells and that it exerts a growth-promoting
effect not only by binding to nuclear estrogen receptors, but also by
activation of the MAP kinase pathway.
This article has been cited by other articles:
![]() |
Z. Zhou, X. Song, A. Berezov, G. Zhang, Y. Li, H. Zhang, R. Murali, B. Li, and M. I. Greene Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states PNAS, April 8, 2008; 105(14): 5465 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brindel, F. Doyon, F. Rachedi, J.-L. Boissin, J. Sebbag, L. Shan, V. Chungue, L. Y. K. Sun, F. Bost-Bezeaud, P. Petitdidier, et al. Menstrual and Reproductive Factors in the Risk of Differentiated Thyroid Carcinoma in Native Women in French Polynesia: A Population-based Case-Control Study Am. J. Epidemiol., January 15, 2008; 167(2): 219 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guignard, T. Truong, Y. Rougier, D. Baron-Dubourdieu, and P. Guenel Alcohol Drinking, Tobacco Smoking, and Anthropometric Characteristics as Risk Factors for Thyroid Cancer: A Countrywide Case-Control Study in New Caledonia Am. J. Epidemiol., November 15, 2007; 166(10): 1140 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lan, D. Cui, K. Nowka, and M. Derwahl Stem Cells Derived from Goiters in Adults Form Spheres in Response to Intense Growth Stimulation and Require Thyrotropin for Differentiation into Thyrocytes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3681 - 3688. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ohnemus, M. Uenalan, J. Inzunza, J.-A. Gustafsson, and R. Paus The Hair Follicle as an Estrogen Target and Source Endocr. Rev., October 1, 2006; 27(6): 677 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vivacqua, D. Bonofiglio, L. Albanito, A. Madeo, V. Rago, A. Carpino, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini 17beta-Estradiol, Genistein, and 4-Hydroxytamoxifen Induce the Proliferation of Thyroid Cancer Cells through the G Protein-Coupled Receptor GPR30 Mol. Pharmacol., October 1, 2006; 70(4): 1414 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Han, J. S. Heo, and Y. J. Lee Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1067 - C1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Heo, Y. J. Lee, and H. J. Han EGF stimulates proliferation of mouse embryonic stem cells: involvement of Ca2+ influx and p44/42 MAPKs Am J Physiol Cell Physiol, January 1, 2006; 290(1): C123 - C133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Truong, L. Orsi, D. Dubourdieu, Y. Rougier, D. Hemon, and P. Guenel Role of Goiter and of Menstrual and Reproductive Factors in Thyroid Cancer: A Population-based Case-Control Study in New Caledonia (South Pacific), a Very High Incidence Area Am. J. Epidemiol., June 1, 2005; 161(11): 1056 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caporali, M. Imai, L. Altucci, M. Cancemi, S. Caristi, L. Cicatiello, F. Matarese, R. Penta, D. K. Sarkar, F. Bresciani, et al. Distinct Signaling Pathways Mediate Stimulation of Cell Cycle Progression and Prevention of Apoptotic Cell Death by Estrogen in Rat Pituitary Tumor PR1 Cells Mol. Biol. Cell, December 1, 2003; 14(12): 5051 - 5059. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |